Raadr Inc (RDAR)

[Slabdad]

Critical Review of Bubae’s Posts on RDAR (Telvantis) on InvestorsHub
Bubae has been an outspoken critic on the RDAR board, particularly focused on the Regulation A offering, alleged share dilution, financial struggles, and stock price volatility. While his vigilance is understandable from a shareholder perspective, several of his points warrant a closer, more balanced examination.

1. Regulation A Offering and Share Dilution
Bubae’s claim: The Reg A offering risks excessive dilution, especially with performance bonus notes converting at a discount, potentially hurting shareholder value.

Why this may be an overstatement:

The Reg A raise was capped at $4.5 million, a relatively modest amount aimed at fueling growth initiatives and product development, not reckless dilution.

Performance bonus notes structured with a discount are common incentive tools to align management’s goals with company growth and shareholder returns. These incentives typically vest on performance milestones, helping ensure management delivers value.

Importantly, the company filed a Form 1-Z to terminate the Reg A offering responsibly, signaling compliance and an intention to protect shareholders from prolonged dilution risk.

2. Financial Performance and Buyback Program
Bubae’s claim: The company is cash flow negative with nearly $2 million net loss in Q1, making a share buyback program unrealistic and potentially misleading.

Critical perspective:

Many early-stage technology companies operate with short-term losses as they invest in product development and market expansion; this is not inherently negative if backed by a sound growth strategy.

The company’s announcement of a buyback program can be seen as a commitment to shareholder value and confidence in future cash flows, even if initial losses exist.

Buybacks can be funded opportunistically, including via non-operational cash sources or capital restructuring, not solely from current cash flow.

3. Stock Price Volatility and Reverse Split Speculation
Bubae’s claim: The stock’s price fluctuations suggest manipulation or a reverse stock split planned to facilitate the Reg A offering pricing.

Balanced view:

Volatility is typical for OTC and early-stage stocks, especially in microcap sectors, and does not necessarily imply manipulation.

Reverse splits are often strategic tools to maintain listing standards or improve marketability, which can be positive for attracting institutional investors and improving liquidity.

The company’s proactive communication and SEC filings show transparency around capital actions rather than attempts to mislead investors.

Supporting Evidence & Summary
Regulatory Compliance: Telvantis filed all required SEC forms (including Form 1-Z) timely, evidencing regulatory diligence.

Business Strategy: The Reg A proceeds aimed at expanding the user base and product enhancements demonstrate a forward-looking growth plan rather than desperation.

Market Norms: Early losses and stock volatility are commonplace in emerging technology firms. Investors should evaluate long-term potential, not just short-term financial snapshots.

Conclusion
While Bubae raises some concerns valid in a highly speculative OTC environment, his perspective sometimes overlooks the broader strategic context and standard corporate finance practices. Telvantis’s approach appears measured and compliant, focusing on growth and shareholder value rather than reckless dilution or manipulation.

Investors should weigh both risks and growth opportunities carefully and look beyond short-term stock price moves or headline losses to the company’s fundamentals and long-term vision.